LENZ Therapeutics

LENZNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$95.361 M

$3.04 -12.28%

Close of 6 Nov 2026

As of 6 Nov 2026, LENZ Therapeutics (LENZ) has a market capitalization of $95.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$19.1M

#2982 by revenue

Earnings

-$82.1M

Loss-making

Shares outstanding

31,420,583

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#112Anavex Life SciencesAVXL$102.4M
#113Black Diamond TherapeuticsBDTX$95.7M
#114LENZ TherapeuticsLENZ$95.4M
#115Neumora TherapeuticsNMRA$92.4M
#116Atara BiotherapeuticsATRA$80.7M

What if LENZ Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$898,674.41

Per share 296,104× higher

Bitcoin $1.53T

$48,625.71

Per share 16,022× higher

Apple $5.02T

$159,633.66

Per share 52,598× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for LENZ Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.